Lyrica (Pfizer)

देश: न्यूज़ीलैंड

भाषा: अंग्रेज़ी

स्रोत: Medsafe (Medicines Safety Authority)

सक्रिय संघटक:

Pregabalin 100mg;  

थमां उपलब्ध:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

INN (इंटरनेशनल नाम):

Pregabalin 100 mg

डोज़:

100 mg

फार्मास्यूटिकल फॉर्म:

Capsule

रचना:

Active: Pregabalin 100mg   Excipient: Colloidal silicon dioxide   Gelatin   Iron oxide red   Lactose monohydrate Maize starch Purified talc Purified water   Sodium laurilsulfate   TekPrint black SW-9008 TekPrint black SW-9009 Titanium dioxide  

पैकेज में यूनिट:

Blister pack, PVC/Al (Starter pack), 14 capsules

वर्ग:

Prescription

प्रिस्क्रिप्शन प्रकार:

Prescription

द्वारा बनाया गया:

Pfizer Asia Pacific Pte Ltd

उत्पाद समीक्षा:

Package - Contents - Shelf Life: Blister pack, PVC/Al (Starter pack) - 14 capsules - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 14 capsules - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al (Starter pack) - 20 capsules - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 20 capsules - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 56 capsules - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 60 capsules - 36 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE/CRC - 14 capsules - 36 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE/CRC - 20 capsules - 36 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE/CRC - 56 capsules - 36 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE/CRC - 60 capsules - 36 months from date of manufacture stored at or below 25°C

प्राधिकरण की तारीख:

2003-12-23

सूचना पत्रक

LYRICA - CMI
1
WARNING: BEFORE TAKING LYRICA, TELL YOUR DOCTOR IF YOU HAVE A HISTORY
OF DRUG ABUSE. LYRICA
POSES RISKS OF MISUSE, ABUSE AND DEPENDENCE. USING LYRICA WITH OTHER
MEDICINES THAT CAN MAKE
YOU FEEL DROWSY SUCH AS SLEEPING TABLETS AND OTHER PAIN RELIEVERS
(E.G. BENZODIAZEPINES AND
OPIOIDS), ANTIHISTAMINES, ANTIDEPRESSANTS, ANTIPSYCHOTICS, CANNABIS,
AND ALCOHOL MAY RESULT IN
SEVERE DROWSINESS, DECREASED AWARENESS, BREATHING PROBLEMS, COMA AND
DEATH. IF YOU HAVE ANY
CONCERN ABOUT TAKING THIS MEDICINE, SPEAK TO YOUR DOCTOR.
LYRICA
_ _
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS
LEAFLET
This leaflet answers some
common questions about
LYRICA.
It does not contain all the
available information. It does
not take the place of talking
to your doctor or pharmacist.
All medicines have risks and
benefits. Your doctor has
weighed the risks of you
taking LYRICA against the
benefits it is expected to have
for you.
IF YOU HAVE ANY CONCERNS
ABOUT TAKING THIS MEDICINE,
ASK YOUR DOCTOR OR
PHARMACIST.
KEEP THIS LEAFLET WITH THE
MEDICINE.
You may need to read it
again.
WHAT LYRICA IS
USED FOR
LYRICA is used to treat
neuropathic pain, which is
pain caused by an
abnormality of, or damage to,
the nerves.
LYRICA is also used to
control epilepsy. Epilepsy is a
condition where you have
repeated seizures (fits).
There are many different
types of seizures, ranging
from mild to severe.
LYRICA belongs to a group
of medicines called
anticonvulsants. These
medicines are thought to
work by controlling brain
chemicals which send signals
to nerves so that seizures do
not happen.
LYRICA also has pain
relieving effects.
LYRICA may be used alone,
or in combination with other
medicines, to treat your
condition.
Your doctor may prescribe
LYRICA in addition to your
current therapy when your
current treatment is no longer
working as well as before.
ASK YOUR DOCTOR IF YOU HAVE
ANY QUESTIONS ABOUT WHY
LYRICA HAS BEEN
PRESCRIBED FOR YOU.
Your doctor may have
prescribed it for another
reason.
This medicine is available
only with a doctor's
prescri

उत्पाद विशेषताएं

LYRICA – data sheet
Page 1 of 22
NEW ZEALAND DATA SHEET
LYRICA is a potential drug of misuse, abuse, and dependence. LYRICA
poses risks of misuse,
abuse
and
dependence
which
can
lead
to
overdose
and
death
especially
when
used
concomitantly with opioids and other CNS depressants. Assess the
patient’s risk of misuse,
abuse or dependence before prescribing and monitor the patient
regularly during treatment,
particularly amongst patients with current or past misuse, abuse or
dependence of opioids
and/or benzodiazepines (see Section 4.4 - Special Warnings and
Precautions for Use).
1.
PRODUCT NAME
LYRICA 25 mg capsules
LYRICA 50 mg capsules
LYRICA 75 mg capsules
LYRICA 100 mg capsules
LYRICA 150 mg capsules
LYRICA 200 mg capsules
LYRICA 225 mg capsules
LYRICA 300 mg capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
LYRICA
contains
the
active
ingredient
pregabalin.
Pregabalin
is
an
analogue
of
the
neurotransmitter gamma-aminobutyric acid (GABA). It has analgesic and
anticonvulsant
activity. Each LYRICA capsule contains 25 mg, 50 mg, 75 mg, 100 mg,
150 mg, 200 mg, 225
mg or 300 mg pregabalin.
EXCIPIENT(S) WITH KNOWN EFFECT:
•
Lactose monohydrate
For the full list of excipients, see section 6.1 List of Excipients.
3.
PHARMACEUTICAL FORM
LYRICA 25 mg capsules: white hard gelatin capsule, marked ‘Pfizer’
on the cap and ‘PGN 25’
on the body with black ink.
LYRICA 50 mg capsules: white hard gelatin capsule, marked ‘Pfizer’
on the cap and ‘PGN 50’
on the body with black ink. The body is also marked with a black band.
LYRICA 75 mg capsules: white and orange hard gelatin capsule, marked
‘Pfizer’ on the cap
and ‘PGN 75’ on the body with black ink.
LYRICA – data sheet
Page 2 of 22
LYRICA 100 mg capsules: orange hard gelatin capsule, marked
‘Pfizer’ on the cap and
‘PGN 100’ on the body with black ink.
LYRICA 150 mg capsules: white hard gelatin capsule, marked
‘Pfizer’ on the cap and
‘PGN 150’ on the body with black ink.
LYRICA 200 mg capsules: light orange hard gelatin capsule, mar